Alaunos Therapeutics, Inc. TCRT
1.09
(0.04)
(3.54%)
as of 25 Sep
- Market cap
- $2.9M
- P/E
- 0.0×
Follow TCRT
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
104.01 | 95.21 | 54.37 | — | — | 62.53 | 39.47 | 7.38 | 278.04 | 449.52 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
(54.62) | (50.04) | (22.72) | — | — | (15.46) | (19.18) | (2.92) | (5.17) | (11.40) |
P/B ratio |
0.00 | 0.00 | 3.14 | — | — | 4.03 | 3.55 | 3.42 | 1.48 | 2.92 |
Price to Tangible BV |
0.00 | 0.00 | 3.14 | — | — | 4.03 | 3.55 | 3.42 | 1.48 | 2.92 |
EV/Sales |
92.19 | 84.11 | 41.87 | — | — | 48.64 | 29.64 | 5.71 | 285.32 | 434.24 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(10.84) | (9.83) | (4.18) | — | — | (2.96) | (3.51) | (0.55) | (0.63) | (2.12) |
EV/FCF |
(10.74) | (9.70) | (4.14) | — | — | (2.81) | (3.49) | (0.58) | (0.87) | (4.16) |
Quick Ratio |
5.13 | 3.40 | 6.71 | 6.63 | 6.52 | 4.81 | 2.19 | 3.10 | 1.58 | 1.71 |
Current Ratio |
6.63 | 4.35 | 8.89 | 8.42 | 7.11 | 4.91 | 2.23 | 4.22 | 3.98 | 2.45 |
Net Debt/EBITDA |
0.49 | 1.34 | 1.16 | 1.35 | 1.39 | 0.70 | 1.09 | 0.20 | 0.23 | 0.33 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 2.16% | 3.29% | 25.42% | 29.19% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.02 | 0.04 | 0.42 | 0.49 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.05 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.34 | 0.75 | (0.36) | 0.35 | 0.71 | 0.78 | 0.77 | 0.86 | 1.06 | 0.69 |
Capex/Depreciation |
(1.90) | (2.00) | (0.80) | (0.45) | (8.67) | (1.12) | (0.05) | 0.37 | 0.00 | (14.00) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (3,423.41%) | 84.16% | (2,441.67%) | (130.47%) | (73.04%) | (86.52%) | (78.11%) | (156.66%) | (111.80%) | (198.10%) | |
| (132.59%) | (69.13%) | 136.80% | (115.39%) | (62.61%) | (65.30%) | (47.22%) | (96.01%) | (84.93%) | (145.99%) | |
ROIC |
0.00% | 0.00% | (141.35%) | (205.22%) | (365.89%) | (791.83%) | (486.27%) | (8,741.58%) | (309.41%) | (343.83%) |
Return on Tangible Assets |
(191.75%) | (102.98%) | 180.83% | (125.21%) | (65.31%) | (106.81%) | (99.05%) | (557.16%) | (226.81%) | (329.86%) |
Average Days of Receivables |
1.12 | 1.09 | 4,660.00 | 0.00 | 0.00 | 1,018.88 | 0.50 | 73.00 | 182.50 | 219.00 |
Research and Development Expense of Revenue |
2,299.83% | 705.65% | 23,379.45% | 0.00% | 0.00% | 12,473.12% | 856.19% | 325,580.00% | 3,620.00% | 27,260.00% |
Selling, General and Administrative Expense of Revenue |
209.55% | 231.62% | 13,642.47% | 0.00% | 0.00% | 6,925.63% | 449.76% | 244,380.00% | 44,600.00% | 57,340.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
123.19% | 132.32% | 5,160.27% | 0.00% | 0.00% | 2,707.04% | 120.74% | 56,000.00% | 4,350.00% | 8,280.00% |
Graham Net Nets |
(0.11) | (0.18) | 0.28 | — | — | 0.18 | 0.20 | 0.29 | 0.67 | 0.19 |
Graham Number |
629.09 | 439.38 | 0.00 | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(24.12%) | (12.16%) | (25.76%) | — | — | (33.93%) | (28.56%) | (169.49%) | (155.50%) | (68.42%) |
Free Cash Flow Yield |
(8.25%) | (9.11%) | (18.59%) | — | — | (27.71%) | (21.51%) | (133.31%) | (118.52%) | (23.25%) |
Revenue per Share |
7.89 | 6.99 | 0.15 | 0.00 | 0.00 | 0.28 | 2.02 | 0.00 | 0.01 | 0.00 |
Operating CF per Share |
(67.06) | (59.85) | (51.67) | (36.47) | (40.77) | (42.98) | (20.19) | (18.84) | (3.10) | (1.47) |
Capex per Share |
(0.63) | (0.81) | (0.48) | (0.25) | (6.99) | (2.32) | (0.13) | 0.84 | 0.00 | (0.05) |
Free Cash Flow per Share |
(67.70) | (60.66) | (52.15) | (36.72) | (47.77) | (45.31) | (20.33) | (18.00) | (3.10) | (1.52) |
Cash per Share |
93.20 | 77.67 | 64.49 | 71.18 | 82.29 | 53.18 | 36.61 | 3.79 | 0.68 | 0.71 |
Shareholders Equity per Share |
(88.88) | (105.98) | 89.39 | 84.82 | 88.67 | 40.60 | 26.64 | 3.94 | 1.29 | 1.11 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(88.88) | (105.98) | 89.39 | 84.82 | 88.67 | 40.60 | 26.64 | 3.94 | 1.29 | 1.11 |
Free Cash Flow |
(58.88) | (55.41) | (49.92) | (41.14) | (66.79) | (64.79) | (29.42) | (28.80) | (4.97) | (2.97) |
Working Capital |
89.08 | 69.93 | 74.80 | 92.97 | 112.22 | 62.79 | 29.63 | 6.31 | 2.06 | 1.18 |
Capital Expenditures |
(0.55) | (0.74) | (0.46) | (0.28) | (9.78) | (3.32) | (0.19) | 1.35 | — | (0.10) |
Net Current Asset Value |
(78.76) | (111.63) | 74.80 | 91.39 | 108.23 | 42.02 | 27.42 | 6.31 | 2.06 | 1.18 |
EV/EBIT |
0.00 | 0.00 | 0.00 | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.08 | 0.12 | 3.14 | 0.00 | 0.00 | 8.35 | 0.07 | (269.20) | 0.00 | 19.60 |
Net Profit Margin |
(2,513.04%) | (1,146.67%) | 94,004.11% | 0.00% | 0.00% | (19,786.68%) | (1,291.24%) | (702,800.00%) | (46,790.00%) | (83,520.00%) |
Price to Operating Income |
0.00 | 0.00 | 0.00 | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.34 | 0.30 | 0.52 | 0.57 | 0.11 | 0.27 | 0.44 | 1,827.00 | 0.00 | 0.08 |
Cash ROIC |
(1,575.71%) | 216.09% | (34.32%) | (23.69%) | (27.57%) | (45.76%) | (34.11%) | (243.71%) | (157.61%) | (83.66%) |
Accounts Receivable Turnover |
29.38 | 319.45 | 0.16 | 0.00 | 0.00 | 0.14 | 5.24 | 2.00 | 3.33 | 1.25 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | — | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | — | 0.00 | — | — | — |
Average Receivables |
0.23 | 0.02 | 0.94 | 2.60 | 4.00 | 2.89 | 0.56 | 0.00 | 0.00 | 0.00 |
Average Payables |
1.08 | 2.29 | 2.56 | 0.81 | 0.93 | 1.16 | 1.38 | 1.00 | 0.57 | 0.56 |
Average Assets |
130.04 | 105.98 | 100.33 | 102.08 | 127.73 | 120.61 | 79.90 | 36.60 | 5.51 | 2.86 |
Average Common Equity |
5.04 | (87.05) | (5.62) | 90.29 | 109.50 | 91.02 | 48.31 | 22.43 | 4.19 | 2.11 |
Columns are period end dates